Financials
Financial year 2025
PHARMACIE CONCORDE DE NAMUR from Sambreville, company number BE0432388881, closed financial year 2025 with a result of € 32,939 after tax. For that financial year PHARMACIE CONCORDE DE NAMUR recorded a gross margin of € 164,533 and equity of € 103,281. Compared with financial year 2024, the result moved from € 56,315 to € 32,939. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 103,281
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 32,939
▼ 42% vs 2024
Profit after tax over the fiscal year.
€ 248,945
▼ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 32,939 paid out
100 % of the profit went to the shareholders, mostly to NOTTE - VASAMULIETTE (100 % of the shares). That is where the money ends up.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 75,294
▲ 53% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,035
▲ € 6,146 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 105,887
▼ 17% vs 2024
€ 21,915 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 27,958
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,657
▲ 65% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 152,402 | € 139,985 | € 163,793 | € 164,533 | |
| Profit after taxes | € 56,397 | € 38,077 | € 56,315 | € 32,939 | ▼ 42% |
| Equity | € 102,203 | € 103,281 | € 103,281 | € 103,281 | |
| Total debts | € 643,923 | € 672,715 | € 605,201 | € 554,528 | ▼ 8% |
| Cash | € 281,176 | € 257,815 | € 281,425 | € 248,945 | ▼ 12% |
| Land & buildings | € 246,848 | € 212,577 | € 178,306 | € 151,145 | ▼ 15% |
| Retained profit | € 21,638 | € 22,715 | € 22,715 | € 22,715 | |
| Dividend | € 55,000 | € 37,000 | € 56,315 | € 32,939 | ▼ 42% |
| Bank debt | € 167,936 | € 147,852 | € 127,174 | € 105,887 | ▼ 17% |
| Balance sheet total | € 746,126 | € 775,996 | € 708,482 | € 657,808 | ▼ 7% |
| Employees (FTE) | 0.8 | 0 | 0 | 0 |
Key figures of PHARMACIE CONCORDE DE NAMUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE CONCORDE DE NAMUR?
What happened at PHARMACIE CONCORDE DE NAMUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 32,939 (▼ 42% vs 2024). Source: NBB ↗
- New establishment in Sambreville. KBO
- Start of the company according to the CBE. KBO
In short
From € 56,397 profit in 2022 to € 32,939 profit in 2025.
Paid € 9,526 in corporate taxes since 2022.
Best year ever: 2022, with € 56,397 profit.
Paid out € 181,254 in dividends to the owners in total.
A new publication or filing at PHARMACIE CONCORDE DE NAMUR? We notify you, reason included.
Follow PHARMACIE CONCORDE DE NAMURDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NOTTE - VASAMULIETTE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE CONCORDE DE NAMURBehind PHARMACIE CONCORDE DE NAMUR are Notte-Vasamuliette SRL, Bernadette Collard and Frédéric & Cécile Notte-Vasamuliette. The shares are held by NOTTE - VASAMULIETTE (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Cécile Vasamuliette
Also active at: Pharmacie Notte-Vasamuliette
Bernadette Collard
Director
Frédéric & Cécile Notte-Vasamuliette
Director
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de Fleurus(MOI) 95
5060 Sambreville
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0432.388.881
- VAT number
- BE 0432.388.881
- Registered office
- Rue de Fleurus(MOI) 95, 5060 Sambreville
- Names & denominations
- PHARMACIE CONCORDE DE NAMUR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 1987
- Peppol
- Active · Active since 17 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Overige detailhandel in nieuwe artikelen neg
Overige gespecialiseerde detailhandel in artikelen, andere dan voedingsmiddelen, n.e.g.